Vascular endothelial growth factor (VEGF), matrix metalloproteinase-9 (MMP-9), and thrombospondin-1 (TSP-1) expression in urothelial carcinomas

Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.

Harold F. Dvorak, Lawrence F. Brown, Michael Detmar et al. · PubMed · 1995 · 3.1K citations

Veterinary Medicine, Physiology, Tumor Microenvironment +9

Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor

Juan Carlos Rodrı́guez-Manzaneque, Timothy F. Lane, Maria-Asunción Ortega et al. · Proceedings of the National Academy of Sciences · 2001 · 467 citations · Full text

Medicine, Cancer Biology, Oncology +17

Rosai and Ackerman???s Surgical Pathology, 9th ed.

Fausto J. Rodríguez · The American Journal of Surgical Pathology · 2004 · 446 citations

Medicine, Pathology, Surgery +4

Thrombospondin-1 Expression in Bladder Cancer: Association With p53 Alterations, Tumor Angiogenesis, and Tumor Progression

Gary D. Grossfeld, David A. Ginsberg, John P. Stein et al. · JNCI Journal of the National Cancer Institute · 1997 · 325 citations

Medicine, Cancer Biology, Oncology +17

Expression and Significance of Vascular Endothelial Growth Factor Receptor 2 in Bladder Cancer

Guangbin Xia, S. Ram Kumar, Debra Hawes et al. · The Journal of Urology · 2006 · 134 citations

Medicine, Oncology, Urology +17